Ben Bates (M.D., University of Mississippi Medical Center; Internal Medicine Residency, Rutgers-RWJMS) is a board-certified physician in internal medicine and is presently an RBHS Instructor. His research focuses on understanding the real-world use, effectiveness and adverse outcomes of treatments. The majority of his research involves the evaluation of treatments among patients with cancer, but he is also involved in research concerning medication use, safety and outcomes in COVID-19 and validation studies on adjudicating claims-based definitions within large databases. His research supported by the New Jersey Commission on Cancer Research evaluates the impact of air pollution on breast cancer treatment effectiveness and potential adverse outcomes. His research supported by the Robert Leet Patterson and Clara Guthrie Patterson Trust assesses the utilization of immune checkpoint inhibitors and adverse outcomes, most notably immune-related cardiovascular toxicity, among higher risk individuals with melanoma and lung cancer. He is thankful for the grant support from the New Jersey Commission on Cancer Research and the Robert Leet Patterson and Clara Guthrie Patterson Trust.